1714.TW
Ho Tung Chemical Corp. [1714.TW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1714.TW Stock Summary
Top 10 Correlated Stocks
1714.TW
In the News
1714.TW Financial details
Company Rating
Strong Buy
Market Cap
8.84B
Income
659.99M
Revenue
20.29B
Book val./share
12.07
Cash/share
7.24
Dividend
0.1
Dividend %
1.11%
Employees
138
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
13.36
Forward P/E
-
PEG
45.24
P/S
0.44
P/B
0.71
P/C
1.21
P/FCF
6.78
Quick Ratio
3.19
Current Ratio
3.9
Debt / Equity
0.19
LT Debt / Equity
0.11
-
-
EPS (TTM)
0.66
EPS next Y
-
EPS next Q
-
EPS this Y
-6.25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
10.76%
Revenue last 5Y
-5.87%
Revenue Q/Q
-0.03%
EPS Q/Q
-47.95%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
3%
ROE
5%
ROC
0.05%
Gross Margin
9%
Oper. Margin
5%
Profit Margin
3%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.22-9.55
52W High
-2.67%
52W Low
+9.5%
RSI
47
Rel Volume
1.08
Avg Volume
1.51M
Volume
1.63M
Perf Week
-0.9%
Perf Month
-3.95%
Perf Quarter
4.78%
Perf Half Y
4.41%
-
-
-
-
Beta
0.511
-
-
Volatility
0.05%, 0.13%
Prev Close
-0.79%
Price
8.76
Change
-0.34%
1714.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 27.37 | 25.77 | 20.15 | 22.54 | 20.16 | |
| Net income per share | 0.36 | 2.39 | 1.45 | 0.64 | 0.6 | |
| Operating cash flow per share | 2.09 | 6.15 | 2.48 | 0.26 | 1.49 | |
| Free cash flow per share | 1.69 | 5.92 | 1.71 | -0.22 | 1.11 | |
| Cash per share | 4.49 | 7.95 | 7.23 | 6.36 | 7.24 | |
| Book value per share | 10.45 | 12.3 | 12.58 | 12.09 | 12.07 | |
| Tangible book value per share | 13.34 | 15.9 | 16.2 | 15.6 | 15.81 | |
| Share holders equity per share | 10.45 | 12.3 | 12.58 | 12.09 | 12.07 | |
| Interest debt per share | 5.58 | 3.79 | 3.23 | 3.12 | 2.39 | |
| Market cap | 7.15B | 10.43B | 11.19B | 8.79B | 9.2B | |
| Enterprise value | 9.33B | 7.43B | 7.87B | 6.42B | 5.09B | |
| P/E ratio | 19.94 | 4.35 | 7.66 | 13.68 | 15.36 | |
| Price to sales ratio | 0.26 | 0.4 | 0.55 | 0.39 | 0.45 | |
| POCF ratio | 3.41 | 1.69 | 4.49 | 33.49 | 6.12 | |
| PFCF ratio | 4.22 | 1.76 | 6.52 | -40.15 | 8.22 | |
| P/B Ratio | 0.68 | 0.85 | 0.89 | 0.72 | 0.76 | |
| PTB ratio | 0.68 | 0.85 | 0.89 | 0.72 | 0.76 | |
| EV to sales | 0.34 | 0.29 | 0.39 | 0.28 | 0.25 | |
| Enterprise value over EBITDA | 6.34 | 1.63 | 3.03 | 4.22 | 3.79 | |
| EV to operating cash flow | 4.45 | 1.2 | 3.16 | 24.44 | 3.39 | |
| EV to free cash flow | 5.51 | 1.25 | 4.59 | -29.3 | 4.55 | |
| Earnings yield | 0.05 | 0.23 | 0.13 | 0.07 | 0.07 | |
| Free cash flow yield | 0.24 | 0.57 | 0.15 | -0.02 | 0.12 | |
| Debt to equity | 0.51 | 0.29 | 0.25 | 0.25 | 0.19 | |
| Debt to assets | 0.23 | 0.15 | 0.13 | 0.13 | 0.1 | |
| Net debt to EBITDA | 1.48 | -0.66 | -1.28 | -1.56 | -3.06 | |
| Current ratio | 2.09 | 2.96 | 3.05 | 2.9 | 4.19 | |
| Interest coverage | 3.9 | 16.88 | 18.08 | 10.8 | 8.57 | |
| Income quality | 3.71 | 2.05 | 1.25 | 0.29 | 2.51 | |
| Dividend Yield | 0.02 | 0 | 0.06 | 0.05 | 0.01 | |
| Payout ratio | 0.43 | 0 | 0.48 | 0.66 | 0.17 | |
| Sales general and administrative to revenue | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Capex to operating cash flow | -0.19 | -0.04 | -0.31 | -1.83 | -0.26 | |
| Capex to revenue | -0.01 | -0.01 | -0.04 | -0.02 | -0.02 | |
| Capex to depreciation | -0.64 | -0.39 | -1.54 | -0.91 | -0.67 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 9.17 | 25.73 | 20.3 | 13.19 | 12.71 | |
| ROIC | 0.03 | 0.19 | 0.09 | 0.04 | 0.04 | |
| Return on tangible assets | 0.02 | 0.1 | 0.06 | 0.03 | 0.03 | |
| Graham Net | 0.27 | 4.05 | 3.87 | 3.74 | 4.62 | |
| Working capital | 6.99B | 9.35B | 9.04B | 8.56B | 10.11B | |
| Tangible asset value | 13.38B | 15.95B | 16.25B | 15.67B | 15.92B | |
| Net current asset value | 3.47B | 6.19B | 6.06B | 6.05B | 6.93B | |
| Invested capital | 0.51 | 0.29 | 0.25 | 0.25 | 0.19 | |
| Average receivables | 5.82B | 4.44B | 3.72B | 3.92B | 3.69B | |
| Average payables | 1.51B | 1.14B | 1.27B | 1.46B | 1.19B | |
| Average inventory | 4.03B | 3.11B | 2.45B | 2.52B | 2.57B | |
| Days sales outstanding | 67.71 | 53.32 | 66.16 | 67.19 | 57.66 | |
| Days payables outstanding | 19.39 | 17.45 | 33.8 | 23.5 | 20.78 | |
| Days of inventory on hand | 56.23 | 43.7 | 53.73 | 44.65 | 51.87 | |
| Receivables turnover | 5.39 | 6.85 | 5.52 | 5.43 | 6.33 | |
| Payables turnover | 18.82 | 20.91 | 10.8 | 15.53 | 17.56 | |
| Inventory turnover | 6.49 | 8.35 | 6.79 | 8.17 | 7.04 | |
| ROE | 0.03 | 0.19 | 0.12 | 0.05 | 0.05 | |
| Capex per share | -0.4 | -0.23 | -0.77 | -0.48 | -0.38 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 5.42 | 5.18 | 4.68 | 5.15 | 5.15 | |
| Net income per share | 0.1 | 0.2 | 0.17 | 0.19 | 0.1 | |
| Operating cash flow per share | 0.68 | 0.09 | 0.55 | 0.38 | 0.47 | |
| Free cash flow per share | 0.56 | -0.05 | 0.48 | 0.34 | 0.34 | |
| Cash per share | 6.35 | 6.27 | 6.88 | 7.32 | 7.24 | |
| Book value per share | 12.07 | 12.33 | 12.13 | 12.45 | 12.07 | |
| Tangible book value per share | 15.56 | 15.91 | 15.63 | 16.27 | 15.81 | |
| Share holders equity per share | 12.07 | 12.33 | 12.13 | 12.45 | 12.07 | |
| Interest debt per share | 3.05 | 3.04 | 3.13 | 3.05 | 2.32 | |
| Market cap | 8.81B | 9.03B | 8.92B | 8.42B | 9.2B | |
| Enterprise value | 6.43B | 6.67B | 6.1B | 4.94B | 5.09B | |
| P/E ratio | 21.34 | 11.11 | 13.07 | 11.28 | 23.1 | |
| Price to sales ratio | 1.61 | 1.73 | 1.89 | 1.62 | 1.78 | |
| POCF ratio | 12.79 | 100.07 | 16.08 | 22.04 | 19.35 | |
| PFCF ratio | 15.67 | -180.77 | 18.27 | 24.77 | 26.96 | |
| P/B Ratio | 0.72 | 0.73 | 0.73 | 0.67 | 0.76 | |
| PTB ratio | 0.72 | 0.73 | 0.73 | 0.67 | 0.76 | |
| EV to sales | 1.18 | 1.28 | 1.29 | 0.95 | 0.98 | |
| Enterprise value over EBITDA | 19.03 | 16.7 | 14.82 | 9.95 | 13.14 | |
| EV to operating cash flow | 9.34 | 73.91 | 11 | 12.93 | 10.71 | |
| EV to free cash flow | 11.45 | -133.51 | 12.5 | 14.53 | 14.92 | |
| Earnings yield | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Free cash flow yield | 0.06 | -0.01 | 0.05 | 0.04 | 0.04 | |
| Debt to equity | 0.25 | 0.24 | 0.26 | 0.24 | 0.19 | |
| Debt to assets | 0.13 | 0.13 | 0.14 | 0.13 | 0.1 | |
| Net debt to EBITDA | -7.02 | -5.91 | -6.85 | -7.01 | -10.6 | |
| Current ratio | 2.9 | 2.62 | 2.61 | 3.9 | 4.19 | |
| Interest coverage | 7.83 | 10.53 | 11.37 | 16.51 | 11.94 | |
| Income quality | 4.06 | 0.38 | 2.3 | 1.16 | 4.78 | |
| Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0.54 | 0 | |
| Sales general and administrative to revenue | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | -0.18 | -1.55 | -0.12 | -0.11 | -0.28 | |
| Capex to revenue | -0.02 | -0.03 | -0.01 | -0.01 | -0.03 | |
| Capex to depreciation | -0.89 | -1.05 | -0.45 | -0.29 | -0.91 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 5.28 | 7.48 | 6.8 | 7.2 | 5.18 | |
| ROIC | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Return on tangible assets | 0 | 0.01 | 0.01 | 0.01 | 0 | |
| Graham Net | 3.73 | 3.83 | 4.06 | 4.76 | 4.62 | |
| Working capital | 8.56B | 8.15B | 8.19B | 10.33B | 10.11B | |
| Tangible asset value | 15.67B | 16.02B | 15.73B | 16.38B | 15.92B | |
| Net current asset value | 6.05B | 6.28B | 6.36B | 7.05B | 6.93B | |
| Invested capital | 0.25 | 0.24 | 0.26 | 0.24 | 0.19 | |
| Average receivables | 4.68B | 4.13B | 3.87B | 3.81B | 3.6B | |
| Average payables | 1.54B | 1.36B | 1.25B | 1.21B | 1.18B | |
| Average inventory | 2.54B | 2.65B | 2.75B | 2.63B | 2.58B | |
| Days sales outstanding | 68.73 | 70.66 | 69.51 | 69.24 | 55.68 | |
| Days payables outstanding | 24.11 | 26.53 | 23.29 | 25.17 | 20.24 | |
| Days of inventory on hand | 45.82 | 53.02 | 56.69 | 48.77 | 50.51 | |
| Receivables turnover | 1.31 | 1.27 | 1.29 | 1.3 | 1.62 | |
| Payables turnover | 3.73 | 3.39 | 3.86 | 3.58 | 4.45 | |
| Inventory turnover | 1.96 | 1.7 | 1.59 | 1.85 | 1.78 | |
| ROE | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Capex per share | -0.13 | -0.14 | -0.07 | -0.04 | -0.13 |
1714.TW Frequently Asked Questions
What is Ho Tung Chemical Corp. stock symbol ?
Ho Tung Chemical Corp. is a TW stock and trading under the symbol 1714.TW
What is Ho Tung Chemical Corp. stock quote today ?
Ho Tung Chemical Corp. stock price is $8.76 today.
Is Ho Tung Chemical Corp. stock public?
Yes, Ho Tung Chemical Corp. is a publicly traded company.
Company Profile
- Volume Average 1.51M
- Market Capitalization 8.84B
- Employee 138
- CEO Ms. Yi-Ju Chen
- Headquarters New Taipei City,TW
- IPO Date 2000-01-04
-
Website
https://www.htgroup.com.tw 
Ho Tung Chemical Corp. develops, manufactures, markets, exports, and sells various chemical products in Taiwan, China, Southeast Asia, and internationally. The company offers normal paraffin; linear alkylbenzene sulfonate produced as intermediate in the production of surfactants for use in detergent; anionic surfactants, including linear alkylbenzene sulphonic acid, and alcohol ether sulfates or sodium laureth sulphate; and cationic surfactants, such as palmityl tri-methyl ammonium chloride, stearyl tri-methyl ammonium chloride, and alkyl dimethyl benzyl ammonium chloride. It also provides non-ionic surfactants comprising fatty alcohols, fatty alcohol ethoxylates, and coconut diethanol amide; cocamidopropyl betaine and dodecyl dimethyl betaine; and de-aromatic solvents used in paints and coatings, consumer products, printing inks, and agricultural chemical applications. In addition, the company engages in the trading of oil and other goods; wholesale and trading of chemicals and fuels; leasing of oil reservoir; manufacture and sale of cement and cement raw materials, PMMA light guide plate, and various commodities; development of new energy and surfactant; and general investment activities. The company was incorporated in 1980 and is based in New Taipei City, Taiwan.
